Genetic glitch can predict response to new class of cancer *****
 

Genetic glitch can predict response to new class of cancer *****
CHICAGO (Reuters) - Patients with colon and other cancers who have a specific defect in genes needed for DNA repair are far more likely to respond to a new class of ***** such as Merck & Co's Keytruda, which enlist the immune system to attack tumors, a new study has shown.http://i2.wp.com/reuters.us.feedspor...f?resize=1%2C1
http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...L8:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...L8:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/iDnHQ1ffHz8